Etoposide (ThyMoorgan GmbH Pharmazir & Co. K.G)


Welcome to the PulseAid listing for the Etoposide drug offered from ThyMoorgan GmbH Pharmazir & Co. K.G. This Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ThyMoorgan GmbH Pharmazir & Co. K.G
NON-PROPRIETARY NAME: Etoposide
SUBSTANCE NAME: ETOPOSIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Topoisomerase Inhibitor [EPC],Topoisomerase Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: APPROVED DRUG PRODUCT MANUFACTURED UNDER CONTRACT
START MARKETING DATE: 2017-10-23
END MARKETING DATE: 0000-00-00


Etoposide HUMAN PRESCRIPTION DRUG Details:

Item DescriptionEtoposide from ThyMoorgan GmbH Pharmazir & Co. K.G
LABELER NAME: ThyMoorgan GmbH Pharmazir & Co. K.G
DEA SCHEDULE:
ACTIVE STRENGTH: 20(mg/mL)
START MARKETING DATE: 2017-10-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 42605-031_e3038a47-3ea0-4467-9a73-31459592b969
PRODUCT NDC: 42605-031
APPLICATION NUMBER: ANDA074290

Other ETOPOSIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Accord Healthcare Inc.Etoposide
BluePoint LaboratoriesEtoposide
Fresenius Kabi USA, LLCEtoposide
Mylan Pharmaceuticals Inc.Etoposide
Teva Parenteral Medicines, Inc.Toposar
ThyMoorgan GmbH Pharmazir & Co. K.GEtoposide
West-Ward Pharmaceuticals CorpEtoposide